Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-15
2008-04-15
Habte, Kahsay T. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S071000, C544S092000
Reexamination Certificate
active
11100860
ABSTRACT:
Thioamide compounds, and specifically, thioamide pyrrole compounds, and preparation thereof are provided. These thioamide compounds can be used as progesterone receptor modulators, in contraception, and in the treatment of progesterone-related maladies.
REFERENCES:
patent: 3536809 (1970-10-01), Applezweig
patent: 3598123 (1971-08-01), Zaffaroni
patent: 3845770 (1974-11-01), Theevwes et al.
patent: 3916899 (1975-11-01), Theevwes et al.
patent: 4008719 (1977-02-01), Theevwes et al.
patent: 4295987 (1981-10-01), Parks
patent: 4959217 (1990-09-01), Sanders et al.
patent: 5124455 (1992-06-01), Lombardo
patent: 5273752 (1993-12-01), Ayer et al.
patent: 5459151 (1995-10-01), Lombardo
patent: 5756127 (1998-05-01), Grizoni et al.
patent: 5817343 (1998-10-01), Burke
patent: 5854388 (1998-12-01), Harding et al.
patent: 6391907 (2002-05-01), Fensome et al.
patent: 6407101 (2002-06-01), Collins et al.
patent: 6417214 (2002-07-01), Ullrich et al.
patent: 6436929 (2002-08-01), Zhang et al.
patent: 6509334 (2003-01-01), Zhang et al.
patent: 6518306 (2003-02-01), Christensen
patent: 6716871 (2004-04-01), Martins et al.
patent: 2004/0002535 (2004-01-01), Fensome et al.
patent: 2004/0006060 (2004-01-01), Fensome et al.
patent: 2004/0006122 (2004-01-01), Fensome et al.
patent: 2004/0014798 (2004-01-01), Fensome et al.
patent: 314206 (1993-10-01), None
patent: WO 98/44964 (1998-10-01), None
patent: WO 00/66581 (2000-11-01), None
patent: WO 2004/000225 (2003-12-01), None
patent: WO 2004/000227 (2003-12-01), None
patent: WO 2004/000230 (2003-12-01), None
patent: WO 2004/000801 (2003-12-01), None
Fensome et al, Novel 5-Aryl-1,3-Dihydro-Indole-2-Thiones: Potent, Orally Active Progesterone Receptor Agonists, Bioorganic & Medicinal Chemistry Letters 13, pp. 1317-1320, (2003).
Testa et al, Prodrugs Revisited: The “Ad Hoc” approach as a complement to Ligand Design, Medicinal Research Reviews, 16(3):233-241, ed. John Wiley & Sons (1996).
Habte Kahsay T.
Howson & Howson LLP
Milowsky Arnold S.
Wyeth
LandOfFree
Thioamide derivatives as progesterone receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thioamide derivatives as progesterone receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thioamide derivatives as progesterone receptor modulators will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3920272